Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?

翻译尚未完成，当前显示原文。

Key PointsNovo Nordisk was first to market with a GLP-1 weight-loss shot and pill.

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。